Interleukin-6 has differential influence on the ability of adjuvant formulations to potentiate antibody reponses to a Plasmodium falciparum blood-stage vaccine
Authors:
- George HuiGHGeorge Hui
- Caryn HashimotoCHCaryn Hashimoto
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Reduced Protective Efficacy of a Blood-Stage Malaria Vaccine by Concurrent Nematode InfectionInfection and Immunity, 2006
- The effect of aging on cognate function and development of immune memoryCurrent Opinion in Immunology, 2005
- Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasisVeterinary Research, 2005
- Vaccine adjuvants: Current state and future trendsImmunology & Cell Biology, 2004
- Innate immunity in aging: impact on macrophage functionAging Cell, 2004
- Dendritic Cells Control B Cell Growth and Differentiation2004
- Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic CellsScience, 2003
- Non-Major Histocompatibility Complex Control of Antibody Isotype and Th1 versus Th2 Cytokines during Experimental Infection of Mice withMycobacterium aviumInfection and Immunity, 2001
- Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720Vaccine, 1997
- The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells.Journal of Experimental Medicine, 1988